Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-7,785
Closed -$579K 293
2021
Q1
$579K Sell
7,785
-350
-4% -$26.6K 0.02% 183
2020
Q4
$592K Sell
8,135
-308
-4% -$21.7K 0.02% 188
2020
Q3
$561K Buy
+8,443
New +$534K 0.02% 176

Other funds holding HOLX

Emerald Advisers's HOLX Position: Q2 2021 in Review

Emerald Advisers sold out of Hologic (HOLX) in Q2 2021, closing a stake of 7,785 shares — an estimated $579K sold.

Emerald Advisers first reported a position in HOLX in Q3 2020 and held it in 3 quarters. The position peaked at $592K in Q4 2020. 624 funds tracked by Wall St. Rank hold HOLX as of Q2 2021.

  • Emerald Advisers reported no remaining Hologic position as of Q2 2021 after selling out during the quarter.
  • Emerald Advisers sold 7,785 Hologic shares in Q2 2021, an estimated $579K.
  • Emerald Advisers first reported a position in Hologic in Q3 2020 and held it in 3 quarters.
  • Emerald Advisers's Hologic position peaked at $592K in Q4 2020.
  • 624 funds tracked by Wall St. Rank held Hologic as of Q2 2021.

Based on Emerald Advisers's 13F filing for Q2 2021, filed 29 Jul 2021.